Better Life Technologies Group, Inc.

<p>Unnessary hospital visits and medical false alarms drive up the cost of health care.&nbsp;</p> <p>&bull;Creating real-time interaction between patients and providers</p> <p>&bull;Patient Falls: We have developed software and hardware that will be contained within our technology that will monitor patient falls</p> <p>&bull;Elopement: &nbsp;Elopement can be a problem with Alzheimers patients where they&nbsp;get confusion and wander&nbsp;off from needed care. &nbsp;&nbsp;Glucose Monitoring Device&nbsp;with its GPS system will allow caregivers to track those who may be putting themselves in danger and continue to monitor their health. &nbsp;</p> <p>&bull;Staff Assistance: &nbsp;The information on our device will can disseminated&nbsp;throughout a care facility allowing easy access to patients may have physical emergencies.&nbsp;</p> <p>Reporting: Real time recording and reporting of vitality information on a patient, is so important,&nbsp;we truly believe that it is the bread and butter of efficient patient care, this coupled with giving the patient the technology to interact with providers so that they can make meaningful and necessary course corrections based upon instruction coming from their primary care providers. We have developed technology covered in our patent that will give the primary care provider the ability to monitor and interact with as many patients as need be, and give providers a treasure chest of meaningful applications which will increase job efficiency:. &nbsp;</p> <p>Applications:</p> <p>&nbsp; People tracking inside and outdoors</p> <p>&nbsp; Can be adapted for Autistic Patient tracking indoors and outdoors</p> <p>&nbsp; Can be adapted for Diabetes Patient needs</p> <p>&nbsp; Can be adapted for Cardiac Patient needs</p> <p>&nbsp; Can be adapted for a variety of other special needs Patient tracking and trace</p> <p>&nbsp; Can be adapted for&nbsp; Sleep Apnea Patients</p> <p>&nbsp;&nbsp;Can be adapted to Alzheimer&#39;s&nbsp; Patients</p> <p>&nbsp;&nbsp;Can&nbsp; be adapted&nbsp; for children and adults with cognitive disabilities to enhance safety</p>

<p>It is important to note, that the&nbsp;Continuous Glucose Market(CGM) market is in its early stages and is rapidly growing. This is mainly due to a rise in the number of diabetics and numerous technological advancements. The CGM market will be valued at $2.9 Billion by 2021 and we believe that with our GDS device, we stand to capture 20% of this market by that time. The standard test strips which represent billions of dollars in spending per year will become obsolete as these CGM devices become more available, giving consumers more information in real time than ever before. Please keep in mind that the above is just the beginning of the scope of our technology.&nbsp; It will cover much more, and will have the ability to monitor cancer patients, stroke patients, patients with neurological disorders and much much more.&nbsp;&nbsp; We also plan to include marketing to patients in 5000 targeted hospitals, residents of senior facilities, home owners, Alzheimer&rsquo;s Association members, cardiac patients, also individuals fighting Obesity, Diabetes, &amp; Stroke, and those with,&nbsp; Epilepsy, and fighting Paraplegic and Quadriplegic disorders, Spinal dangers, Sleep Apnea, Thyroid disease, high blood pressure, Cancer, Parkinson&#39;s, Blood clots, and individuals at high risk during travel. &nbsp;To sum it up, we plan to do the following:&nbsp;</p> <p>&bull;We monitor patients in the hospitals and in their homes by transmitting and receiving vital information from their glucose, cholestoral, and electrolytes readings that would be used in weight loss and physical fitness goals,&nbsp;including imaging records, cast wave files and video files which will create better tracking. Imagine an emergency and calling and&nbsp;sending for an ambulance and having the parametics receiving vital information on the patient before they arrive. &nbsp;How powerful would that be? I would be a game-changer. &nbsp;To sum it up, the major accomplishments that our technology promises are the following:&nbsp;</p> <p>&bull;Give patients the ability to interact with their doctors&nbsp;and their caretakers real time&nbsp;and make needed course corrections in terms of their health. &nbsp;</p> <p>&bull; Give patients the ability to non-invasively monitor Glucose, Aortic Blood Pressure, Electrolyte readings, and much more .&nbsp;</p> <p>&bull;Saves patient&nbsp;lives and money by creating a superior delivery system for remote health care utilizing advanced wireless technology including a method of incryption that will protect patient information. &nbsp;</p> <p>Finally, we need your support and will reward your gifts according the the patient reward section. &nbsp;Please understand that we may need FDA approvals prior to giving out samples. &nbsp;However we think we can give your pretty cool stuff for your support. &nbsp;Help us to help humanity!&nbsp;</p>

<p>&nbsp;In the month of August we&nbsp;received Endorsement from the University of Arkansas which is open to use its faculty and staff to build our device from our present prototype, to the ready for market edition, including setting up manufacturing, and facilitating partnerships globally working hand-in-hand with Fallbrook Engineering of Luecacia California. &nbsp;Fallbrook Engineering was established in 1981 and is one of the premire engineering firms in the country specializing in medical device development and manufacturing. Further, Fallbrook is one of the top developers of medical devices doing work for major hospitals such as Scripps La Jolla---They are co-inventors of the latest stent technologies along with Dr. Paul Tierstien MD Chief of Cardiology at Scripps and they do a lot of work with Qualcomm)&nbsp;. &nbsp;Putting these two companies together creates a powerful team geared to successfully solve the challenge of non-invasive diabetic monitoring. &nbsp;The University is interested in the huge impact that a truly non-invasive, wireless wearable device will have on Glucose reading and monitoring, and disease management. &nbsp;ie. Cancer, neurological diseases and chemical dependencies. &nbsp;Given this backdrop, a parnership with a hospital, provider, or device company who is willing to provide needed financing will be key in attaining the success necessary to create a revolutionary working piece of technology that provides the technology to monitor diabetes which has become the worst plagues of our society. &nbsp;</p> <p>The partnership with a medical provider, physician or medical device company who has the connections and established markets for Aortic blood pressure reading, weight loss, and Kiosk applications would stand be the forefront to a billion dollar industry. Lastly, the&nbsp;University will need funding to complete its work and will work in conjunction with our engineers, and those of Fallbrook Engineering.</p> <p>We are currently completing the second stage of our prototype development at this stage we are building a chamber the size of a shoe box that will read gasses from the epidermis. &nbsp;The shoebox chamber would be used in Kiosks at Rite Aids and CVS stores. &nbsp;It would replace the current methods of reading blood pressure and give the user a much broader scope of measuring pertainent health and vitality information. &nbsp;</p> <p>3. We are in private talks with US based Molex Engineering, FoxConn of Tiawan, and Huawei of China.&nbsp; We have garnered major interest from several major companies who is looking for us to develop an aspect of our technology. &nbsp;Yet, we believe the best partnership would be with a device company who already had established markets in our technological space.&nbsp; We are interested in meaningful long-term partnerships that can help channel a technology&nbsp;that will be as revolutionary to the medical device industry as apple was to the computer industry. &nbsp;</p>